−0.14 CAD
−1.99 M CAD
17.52 M CAD
16.74 M
About CRESCITA THERAPEUTICS INC
Sector
CEO
Serge Verreault
Headquarters
Laval
Website
Founded
2016
FIGI
BBG008HJRTD5
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. Its products include Pliaglis, Alyria, Laboratoire Dr Renaud, and Pro-Derm. It operates through the following business segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells non-prescription skincare products. The Licensing and Royalties segment refers to the licensing related to its prescription product. The Manufacturing and Services segment relates to the sale of topical products and product development services. The company was founded on March 1, 2016 and is headquartered in Laval, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CTX is 0.55 CAD — it has decreased by −5.17% in the past 24 hours. Watch CRESCITA THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange CRESCITA THERAPEUTICS INC stocks are traded under the ticker CTX.
CTX stock has fallen by −1.79% compared to the previous week, the month change is a −5.17% fall, over the last year CRESCITA THERAPEUTICS INC has showed a 37.50% increase.
CTX stock is 5.45% volatile and has beta coefficient of 0.30. Track CRESCITA THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is CRESCITA THERAPEUTICS INC there?
Today CRESCITA THERAPEUTICS INC has the market capitalization of 10.51 M, it has increased by 1.50% over the last week.
Yes, you can track CRESCITA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
CTX net income for the last quarter is −1.04 M CAD, while the quarter before that showed −926.00 K CAD of net income which accounts for −11.88% change. Track more CRESCITA THERAPEUTICS INC financial stats to get the full picture.
No, CTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 80.00 employees. See our rating of the largest employees — is CRESCITA THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CRESCITA THERAPEUTICS INC EBITDA is −1.68 M CAD, and current EBITDA margin is −2.57%. See more stats in CRESCITA THERAPEUTICS INC financial statements.
Like other stocks, CTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CRESCITA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CRESCITA THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CRESCITA THERAPEUTICS INC stock shows the sell signal. See more of CRESCITA THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.